These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37122603)

  • 1. COVID-19 related biliary injury: A review of recent literature.
    Yadlapati S; Jarrett SA; Baik D; Chaaya A
    World J Gastroenterol; 2023 Apr; 29(14):2127-2133. PubMed ID: 37122603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP.
    Leonhardt S; Grajecki D; Geisel D; Fehrenbach U; Adler A; Leonhardt J; Horst D; Kurth F; Thibeault C; Janssen HJ; Kaul T; Faiss S; Tacke F; Jürgensen C
    Am J Gastroenterol; 2024 Apr; 119(4):748-759. PubMed ID: 37843039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID cholangiopathy: A narrative review.
    Caballero-Alvarado J; Zavaleta Corvera C; Merino Bacilio B; Ruiz Caballero C; Lozano-Peralta K
    Gastroenterol Hepatol; 2023; 46(6):474-482. PubMed ID: 36174796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.
    Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER
    Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of COVID Cholangiopathy and Literature Review.
    Kode V; Puetz J; Razzak AN; Jha P
    WMJ; 2023 Dec; 122(5):372-376. PubMed ID: 38180927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-COVID-19 severe cholangiopathy: report of 6 cases].
    Santisteban Arenas MT; Osorio Castrillón LM; Guevara Casallas LG; Niño Ramírez SF
    Rev Gastroenterol Peru; 2022; 42(1):53-57. PubMed ID: 35896075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.
    Sarkis Y; Saleem N; Vuppalanchi R; Gromski M
    Hepat Med; 2023; 15():27-32. PubMed ID: 37013139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary Tract Injury in Patients With COVID-19: A Review of the Current Literature.
    Faruqui S; Shanbhogue K; Jacobson IM
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):380-387. PubMed ID: 36397771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
    Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
    Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID-19 Cholangiopathy: A Systematic Review.
    Yanny B; Alkhero M; Alani M; Stenberg D; Saharan A; Saab S
    J Clin Exp Hepatol; 2023; 13(3):489-499. PubMed ID: 36337085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 Cholangiopathy: A Novel Entity.
    Roth NC; Kim A; Vitkovski T; Xia J; Ramirez G; Bernstein D; Crawford JM
    Am J Gastroenterol; 2021 May; 116(5):1077-1082. PubMed ID: 33464757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic liver injury: A rare but fatal complication during and after COVID-19 infection.
    Wongtanasarasin W
    World J Virol; 2022 Nov; 11(6):435-442. PubMed ID: 36483106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings.
    Kim HY; Lee SS
    Korean J Radiol; 2023 Nov; 24(11):1167-1171. PubMed ID: 37899526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.